Matt Yang

Matt Yang is an experienced finance professional with a strong background in corporate finance and financial planning and analysis. As Vice President of Corporate Finance & FP&A at Cytokinetics since September 2018, Matt has previously held senior roles at Intarcia Therapeutics, Genentech, and Roche, demonstrating expertise in managing financial processes and forecasts for significant sales portfolios. Matt's earlier experience includes positions at Visa, SPL WorldGroup, and Pitney Bowes, contributing to a well-rounded skill set in financial management. Matt holds an MBA in Finance and Corporate Strategy from the University of Michigan's Stephen M. Ross School of Business and a Bachelor's degree in Business from National Taiwan University.